These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9649013)

  • 1. A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy.
    Tazuma S; Kajiyama G; Mizuno T; Yamashita G; Miura H; Kajihara T; Hattori Y; Miyake H; Nishioka T; Hyogo H; Sunami Y; Yasumiba S; Ochi H; Matsumoto T; Abe A; Adachi K; Omata F; Ueno F; Sugata F; Ohguri S; Shibata H; Kokubu S
    J Clin Gastroenterol; 1998 Jun; 26(4):287-91. PubMed ID: 9649013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin added to ursodeoxycholic acid does not enhance disappearance of gallstone fragments after shock wave therapy.
    Sackmann M; Koelbl R; Pauletzki J; Cremer P; Klueppelberg UG; von Ritter C; Sauter G; Holl J; Seidel D; Paumgartner G
    Z Gastroenterol; 1995 Oct; 33(10):585-9. PubMed ID: 7502550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial. The British-Italian Gallstone Study group.
    Petroni ML; Jazrawi RP; Pazzi P; Lanzini A; Zuin M; Pigozzi MG; Fracchia M; Galatola G; Alvisi V; Heaton KW; Podda M; Northfield TC
    Aliment Pharmacol Ther; 2001 Jan; 15(1):123-8. PubMed ID: 11136285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor.
    Chapman BA; Burt MJ; Chisholm RJ; Allan RB; Yeo KH; Ross AG
    Dig Dis Sci; 1998 Feb; 43(2):349-53. PubMed ID: 9512129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Per oral gallstone dissolution therapy].
    Sugata F
    Nihon Rinsho; 1993 Jul; 51(7):1785-90. PubMed ID: 8366596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease.
    Smit JW; van Erpecum KJ; Renooij W; Stolk MF; Edgar P; Doornewaard H; Vanberge-Henegouwen GP
    Hepatology; 1995 Jun; 21(6):1523-9. PubMed ID: 7768495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy.
    Tudyka J; Kratzer W; Janowitz P; Mason R; Wechsler JG
    Am J Gastroenterol; 1995 Nov; 90(11):1942-8. PubMed ID: 7484996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
    Angelin B; Ewerth S; Einarsson K
    J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sedimentable sterols in gallstone patients before and during ursodeoxycholic acid and simvastatin treatments.
    Miettinen TE; Vuoristo M
    Scand J Gastroenterol; 1998 Dec; 33(12):1297-302. PubMed ID: 9930394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia.
    Mazzella G; Parini P; Festi D; Bazzoli F; Aldini R; Roda A; Tonelli D; Cipolla A; Salzetta A; Roda E
    Hepatology; 1992 Jun; 15(6):1072-8. PubMed ID: 1592346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
    Jüngst D; Brenner G; Pratschke E; Paumgartner G
    J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism.
    Hillebrant CG; Nyberg B; Gustafsson U; Sahlin S; Björkhem I; Rudling M; Einarsson C
    Eur J Clin Invest; 2002 Jul; 32(7):528-34. PubMed ID: 12153554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution.
    Festi D; Frabboni R; Bazzoli F; Sangermano A; Ronchi M; Rossi L; Parini P; Orsini M; Primerano AM; Mazzella G
    Gastroenterology; 1990 Dec; 99(6):1779-85. PubMed ID: 2227291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.
    Podda M; Zuin M; Battezzati PM; Ghezzi C; de Fazio C; Dioguardi ML
    Gastroenterology; 1989 Jan; 96(1):222-9. PubMed ID: 2642440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin and ursodeoxycholic acid for rapid gallstone dissolution.
    Bateson MC
    Lancet; 1990 Nov; 336(8724):1196. PubMed ID: 1978058
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
    Smit JW; Van Erpecum KJ; Portincasa P; Renooij W; Erkelens DW; Van Berge-Henegouwen GP
    Gut; 1995 Nov; 37(5):654-9. PubMed ID: 8549941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of ursodeoxycholic acid alone and ursodeoxycholic acid plus low-dose acetylsalicylic acid on radiolucent gallstones.
    Tuncer I; Harman M; Mercan R; Oztürk M; Arslan I; Meral C; Türkdoğan MK
    Turk J Gastroenterol; 2003 Jun; 14(2):91-6. PubMed ID: 14614633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol metabolism in human gallbladder mucosa: relationship to cholesterol gallstone disease and effects of chenodeoxycholic acid and ursodeoxycholic acid treatment.
    Sahlin S; Ahlberg J; Reihnér E; Ståhlberg D; Einarsson K
    Hepatology; 1992 Aug; 16(2):320-6. PubMed ID: 1639340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of simvastatin on hepatic cholesterol metabolism, bile lithogenicity and bile acid hydrophobicity in patients with gallstones.
    Smith JL; Roach PD; Wittenberg LN; Riottot M; Pillay SP; Nestel PJ; Nathanson LK
    J Gastroenterol Hepatol; 2000 Aug; 15(8):871-9. PubMed ID: 11022827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.